U S PHYSICAL THERAPY INC /NV Net Income (Loss) Attributable to Redeemable Noncontrolling Interest
U S PHYSICAL THERAPY INC /NV (USPH) reported Net Income (Loss) Attributable to Redeemable Noncontrolling Interest of $8.43 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest · last filed 2019-03-18
- U S PHYSICAL THERAPY INC /NV net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2017-12-31 was -$4.12M.
- U S PHYSICAL THERAPY INC /NV net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2017-09-30 was $1.28M, a 51.21% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2017-06-30 was $1.79M.
- U S PHYSICAL THERAPY INC /NV net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2017-03-31 was $1.29M.
- U S PHYSICAL THERAPY INC /NV net income (loss) attributable to redeemable noncontrolling interest for fiscal 2018 was $8.43M, a 3356.15% increase from fiscal 2017.
- U S PHYSICAL THERAPY INC /NV net income (loss) attributable to redeemable noncontrolling interest for fiscal 2017 was $244.00K.
- U S PHYSICAL THERAPY INC /NV net income (loss) attributable to redeemable noncontrolling interest for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- U S PHYSICAL THERAPY INC /NV net income (loss) attributable to redeemable noncontrolling interest for fiscal 2015 was $3.54M.
| Period end | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $8.43M 10-K · filed 2019-03-18 | |||||||
| 2017-12-31 | -$4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$2.84M derived: sum of 2 quarters · filed 2019-03-18 | -$1.05M derived: sum of 3 quarters · filed 2019-03-18 | $244.00K 10-K · filed 2019-03-18 | $6.05M 10-K · filed 2018-03-14 | |||
| 2017-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.07M derived: sum of 2 quarters · filed 2017-11-07 | $4.37M 10-Q · filed 2017-11-07 | $1.22M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $3.08M 10-Q · filed 2017-08-07 | -$65.00K derived: sum of 3 quarters · filed 2019-03-18 | $2.57M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | $1.29M 10-Q · filed 2017-06-29 | -$1.85M derived: sum of 2 quarters · filed 2019-03-18 | $782.00K derived: sum of 3 quarters · filed 2019-03-18 | |||||
| 2016-12-31 | -$3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$512.00K derived: sum of 2 quarters · filed 2019-03-18 | $0.00 10-K · filed 2019-03-18 | $4.06M 10-K · filed 2017-06-07 | ||||
| 2016-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.15M 10-Q · filed 2017-11-07 | $548.00K 10-Q · filed 2016-11-04 | |||||
| 2016-06-30 | $512.00K 10-Q · filed 2016-08-05 | |||||||
| 2015-12-31 | $19.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | $13.63M derived: sum of 2 quarters · filed 2017-06-07 | $7.70M derived: sum of 3 quarters · filed 2017-06-07 | $3.54M 10-K · filed 2017-06-07 | ||||
| 2015-09-30 | -$5.82M 10-Q · filed 2015-11-05 | -$11.75M derived: sum of 2 quarters · filed 2015-11-05 | -$15.91M 10-Q · filed 2015-11-05 | |||||
| 2015-06-30 | -$5.93M 10-Q · filed 2015-08-06 | -$10.09M 10-Q · filed 2015-08-06 | ||||||
| 2015-03-31 | -$4.17M 10-Q · filed 2015-05-07 | |||||||
| 2014-09-30 | -$5.22M 10-Q · filed 2015-11-05 | -$11.53M derived: sum of 2 quarters · filed 2015-11-05 | -$14.79M 10-Q · filed 2015-11-05 | |||||
| 2014-06-30 | -$6.31M 10-Q · filed 2015-08-06 | $6.31M 10-Q · filed 2014-08-07 | -$9.57M 10-Q · filed 2015-08-06 | $9.57M 10-Q · filed 2014-08-07 | ||||
| 2014-03-31 | -$3.26M 10-Q · filed 2015-05-07 | $3.26M 10-Q · filed 2014-05-09 | ||||||
| 2013-09-30 | -$227.00K 10-Q · filed 2014-11-07 | $4.69M derived: sum of 2 quarters · filed 2014-11-07 | -$8.86M 10-Q · filed 2014-11-07 | |||||
| 2013-06-30 | $4.91M 10-Q · filed 2014-08-07 | $8.63M 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | $3.72M 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |